| Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase |
122 |
| Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein |
93 |
| Favipiravir as a potential countermeasure against neglected and emerging RNA viruses |
72 |
| Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes |
58 |
| The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold |
58 |
| In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit |
56 |
| African swine fever |
48 |
| Advances in respiratory virus therapeutics - A meeting report from the 6th for isirv Antiviral Group conference |
45 |
| The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts |
34 |
| Antivirals targeting the polymerase complex of influenza viruses |
31 |
| Broad-spectrum antiviral activity of the eIF4A inhibitor silvestrol against corona- and picornaviruses |
30 |
| Innovation and trends in the development and approval of antiviral medicines: 1987-2017 and beyond |
29 |
| West Nile virus epizootic in Germany, 2018 |
28 |
| Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines |
28 |
| Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment |
28 |
| Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model |
22 |
| Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors and status of novel antivirals, 2016-2017 |
22 |
| An evaluation of Chloroquine as a broad-acting antiviral against Hand, Foot and Mouth Disease |
21 |
| The evolution of antiviral nucleoside analogues: A review for chemists and non-chemists. Part II: Complex modifications to the nucleoside scaffold |
21 |
| Ivermectin inhibits DNA polymerase UL42 of pseudorabies virus entrance into the nucleus and proliferation of the virus in vitro and vivo |
20 |
| A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization |
19 |
| Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus |
18 |
| Novel activities of safe-in-human broad-spectrum antiviral agents |
18 |
| Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection |
17 |
| The role of adjuvant immunomodulatory agents for treatment of severe influenza |
17 |
| The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals |
17 |
| New therapies for human cytomegalovirus infections |
17 |
| Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus |
16 |
| Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B |
16 |
| HIV shock and kill therapy: In need of revision |
16 |
| Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012-2018 |
16 |
| Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters |
15 |
| The European Virus Archive goes global: A growing resource for research |
15 |
| Dengue drug discovery: Progress, challenges and outlook |
14 |
| Antiviral activity of pinocembrin against Zika virus replication |
14 |
| Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme |
14 |
| IRF- RIG-I and MDA5 display potent antiviral activities against norovirus coordinately induced by different types of interferons |
13 |
| Antiviral activity of silymarin against Mayaro virus and protective effect in virus-induced oxidative stress |
13 |
| Cell culture systems for the study of hepatitis E virus |
13 |
| Antiviral activity of metal chelates of caffeic acid and similar compounds towards herpes simplex, VSV-Ebola pseudotyped and vaccinia viruses |
13 |
| Favipiravir inhibits in vitro Usutu virus replication and delays disease progression in an infection model in mice |
13 |
| Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets |
12 |
| Significant inhibition of re-emerged and emerging swine enteric coronavirus in vitro using the multiple shRNA expression vector |
12 |
| In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review |
12 |
| Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses |
12 |
| Subgenomic flaviviral RNAs: What do we know after the first decade of research |
12 |
| Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease |
12 |
| Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection |
12 |
| Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference |
12 |
| Favipiravir (T-705) but not ribavirin is effective against two distinct strains of Crimean-Congo hemorrhagic fever virus in mice |
12 |
